[WCIR2009]Y.Handelsman教授访谈:胰岛素抵抗与糖尿病临床实践
内容概要:糖尿病治疗的主要策略曾经一直是控制血糖以预防或延缓各种糖尿病并发症的出现。现在,其他因素包括高血压和肥胖以及在这些代谢异常中它们之间的的关系,迫使我们将这个异常视为一个整体看待。意识到这一点之后,糖尿病治疗的策略可曾有所改变......
中文内容已更新 2009-12-01
International Diabetes : We were talking earlier about the fact that the name of the meeting has changed. Why is that?
《国际糖尿病》:之前我们谈论过会议的名称改变的事实,那么请问为什么要改变呢?
Dr Handelsman: For years this was the World Congress on Insulin Resistance Syndrome but over time we recognized that even our own definition of insulin resistance syndrome says any abnormality from one to four, so if one component of insulin resistance syndrome creates abnormality and is the risk for cardiovascular disease and other conditions then actually the name syndrome has lost its particular meaning and therefore we would rather call it a World Congress on Insulin Resistance.
Handlesman教授:多年以来一直称为胰岛素抵抗综合症国际会议,随着时间的推移,我们认识到即使我们自己定义为胰岛素抵抗综合症,但实际上也是指这个综合症中的任何异常。胰岛素抵抗综合症中的任何疾病出现异常,都是心血管疾病的危险因素,还有其它一些情况。因此说综合症这个名称已经失去了它特有的意义,因此我们改称为胰岛素抵抗国际会议。
[1] [2] [3] [4] [5] [6] 下一页